Very happy to be invited yesterday at MEDVIA’s and BioWin’s sold-out (!) #sfh2024 congress on AI, Data & Digitalisation and explain RheumaFinder’s journey in creating clinical impact by early detection and follow-up of rheumatic diseases in everyday medical imaging. Insightful presentations at this HST Group – Health, Science and Technology Group supported congress highlighted the exciting momentum that is cooking in Belgium to foster a vibrant healthcare AI ecosystem through an expected collaboration with the default stakeholders ! #pharma #bigdata #healthinnovation #clinicaltrials
This post was also published on our LinkedIn page.